These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19916854)

  • 21. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
    Wenning GK; Ben-Shlomo Y; Hughes A; Daniel SE; Lees A; Quinn NP
    J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):434-40. PubMed ID: 10727478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A patient with multiple system atrophy presenting prolonged levodopa-responsive parkinsonism and off-dystonia of the trunk].
    Nakanishi I; Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2003 Jul; 55(7):605-8. PubMed ID: 12910995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of dysautonomic symptoms in distinguishing Parkinson's disease (PD) from multiple system atrophy (MSA-P) within a year of developing motor symptoms.
    Ragothaman M; Swaminath PV; Sarangmath N; Koshy S; Adhyam M; Subbakrishna DK; Mathias CJ; Muthane UB
    J Assoc Physicians India; 2011 Feb; 59():95-8. PubMed ID: 21751644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test.
    Acharya M; Banerjee S; Chatterjee A; Mukherjee A; Biswas S; Gangopadhyay G; Biswas A
    Neurol India; 2021; 69(2):430-434. PubMed ID: 33904468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
    Asayama S; Wate R; Kaneko S; Asayama T; Oki M; Tsuge A; Nagashima M; Morita J; Nakamura S; Nakamura M; Nishii M; Fujita K; Saito A; Nakano S; Ito H; Kusaka H
    Acta Neurol Scand; 2013 Sep; 128(3):160-5. PubMed ID: 23410225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor activation in multiple system atrophy and Parkinson disease: a PET study.
    Payoux P; Brefel-Courbon C; Ory-Magne F; Regragui W; Thalamas C; Balduyck S; Durif F; Azulay JP; Tison F; Blin O; Esquerre JP; Rascol O
    Neurology; 2010 Sep; 75(13):1174-80. PubMed ID: 20876470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
    Quattrone A; Nicoletti G; Messina D; Fera F; Condino F; Pugliese P; Lanza P; Barone P; Morgante L; Zappia M; Aguglia U; Gallo O
    Radiology; 2008 Jan; 246(1):214-21. PubMed ID: 17991785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).
    Moreno-López C; Santamaría J; Salamero M; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Overeem S; Bloem B; Aarden W; Canesi M; Antonini A; Duerr S; Wenning GK; Poewe W; Rubino A; Meco G; Schneider SA; Bhatia KP; Djaldetti R; Coelho M; Sampaio C; Cochen V; Hellriegel H; Deuschl G; Colosimo C; Marsili L; Gasser T; Tolosa E
    Arch Neurol; 2011 Feb; 68(2):223-30. PubMed ID: 21320989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.
    Vasta R; Nicoletti A; Mostile G; Dibilio V; Sciacca G; Contrafatto D; Cicero CE; Raciti L; Luca A; Zappia M
    PLoS One; 2017; 12(2):e0172145. PubMed ID: 28207803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apraxia in Parkinson's disease and multiple system atrophy.
    Uluduz D; Ertürk O; Kenangil G; Ozekmekçi S; Ertan S; Apaydin H; Erginöz E
    Eur J Neurol; 2010 Mar; 17(3):413-8. PubMed ID: 20050896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinsonism. Multiple system atrophy.
    Wenning GK; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):187-204. PubMed ID: 9426875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.
    Herbert MK; Eeftens JM; Aerts MB; Esselink RA; Bloem BR; Kuiperij HB; Verbeek MM
    Parkinsonism Relat Disord; 2014 Jan; 20(1):112-5. PubMed ID: 24075122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy.
    Matsuura K; Maeda M; Yata K; Ichiba Y; Yamaguchi T; Kanamaru K; Tomimoto H
    Eur Neurol; 2013; 70(1-2):70-7. PubMed ID: 23796701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report.
    Högl B; Seppi K; Brandauer E; Wenning G; Poewe W
    Mov Disord; 2001 Nov; 16(6):1177-9. PubMed ID: 11748758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
    Goldstein DS; Kopin IJ; Sharabi Y; Holmes C
    Clin Auton Res; 2015 Feb; 25(1):61-7. PubMed ID: 25638582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Young-onset multiple system atrophy: Clinical and pathological features.
    Batla A; De Pablo-Fernandez E; Erro R; Reich M; Calandra-Buonaura G; Barbosa P; Balint B; Ling H; Islam S; Cortelli P; Volkmann J; Quinn N; Holton JL; Warner TT; Bhatia KP
    Mov Disord; 2018 Jul; 33(7):1099-1107. PubMed ID: 30153390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential diagnostic value of a battery of oculomotor evaluation in Parkinson's Disease and Multiple System Atrophy.
    Zhou H; Wang X; Ma D; Jiang Y; Li F; Sun Y; Chen J; Sun W; Pinkhardt EH; Landwehrmeyer B; Ludolph A; Zhang L; Zhao G; Wang Z
    Brain Behav; 2021 Jul; 11(7):e02184. PubMed ID: 34056874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?
    Gandor F; Vogel A; Claus I; Ahring S; Gruber D; Heinze HJ; Dziewas R; Ebersbach G; Warnecke T
    Mov Disord; 2020 Dec; 35(12):2174-2183. PubMed ID: 32757231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.